OTC · Medical - Pharmaceuticals

Immunovia AB (IMMVF) Stock

$0.02 +0.00% OTC: IMMVF Healthcare

Immunovia AB engages in the development of methods for diagnosing complex forms of cancer and autoimmune diseases. Its technology platform, IMMray, focuses on the early diagnosis of cancer, predicts disease progression, and monitors therapeutic responsiveness of cancers.

Valuation

MetricValue
Price$0.02
Market Cap$6.11M
P/E Ratio-0.65
P/B Ratio2.60
P/S Ratio66.93
EPS (TTM)$-0.42
52-Week High$0.15
52-Week Low$0.02
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-353.07%
ROA-162.19%
ROCE-171.64%
Gross Margin-8000.00%
Operating Margin-8000.00%
Net Margin-14600.00%
Debt/Equity0.01
Current Ratio3.05

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$1.0M$2.0M$1.0M$1.0M
Operating Profit$-167.0M$-191.0M$-296.0M$-109.0M$-80.0M
Net Profit$-156.0M$-168.0M$-309.0M$-77.0M$-146.0M
EPS$-6.40$-6.89$-7.95$-0.93$-0.42
Op Margin-19742.7%-16694.3%-18822.9%-11752.0%-11774.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$494.0M$301.0M$99.0M$33.0M$88.0M
Total Liabilities$60.0M$57.0M$32.0M$21.0M$23.0M
Cash$287.0M$106.0M$77.0M$25.0M$77.0M
Borrowings$33.0M$38.0M$4.0M$1.0M$1.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-153.0M$-176.0M$-147.0M$-97.0M$-78.0M
Investing Cash Flow$-48.0M$-4.0M$2.0M$0$-6.0M
Financing Cash Flow$-6.0M$-6.0M$-6.0M$-8.0M$-1.0M
Net Cash Flow$-181.0M$-181.0M$-29.0M$-51.0M$56.0M
Free Cash Flow$-177.0M$-177.0M$-148.0M$-97.0M$-78.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-0.08
FCF Yield-130.85%
Quick Ratio3.04
Interest Coverage-2.94
Return 1Y-61.59%
Return 3Y-98.17%
Return 5Y—

Ownership

Insiders Held10.70%
Institutions Held17.44%
Institutions Float Held19.53%
Institutional HolderSharesReport Date
SPDR INDEX SHARES FUNDS-SPDR(R) Portfolio Europe ETF72025-11-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Immunovia AB

Immunovia AB engages in the development of methods for diagnosing complex forms of cancer and autoimmune diseases. Its technology platform, IMMray, focuses on the early diagnosis of cancer, predicts disease progression, and monitors therapeutic responsiveness of cancers. The company was founded by Karl Arne Krister Borrebaeck on May 24, 2007 and is headquartered in Lund, Sweden.

Immunovia AB is headquartered in SE.

Immunovia AB (IMMVF) stock trades at $0.02 with a market capitalization of $6.11M. The stock is valued at a price-to-earnings (P/E) ratio of -0.65, price-to-book of 2.60, price-to-sales of 66.93. Over the past 52 weeks the stock has ranged between $0.02 and $0.15, and currently trades 86.7% below its 52-week high.

On profitability, Immunovia AB generates a return on equity (ROE) of -353.07%, return on capital employed of -171.64%, an operating margin of -8000.00%, a net profit margin of -14600.00%.

Official website: www.immunovia.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides